Skip to Main Content
Yale School of Public Health
Give Now
YSPH Home

INFORMATION FOR

COVID-19 Modeling

Publications from YSPH Public Health Modeling Unit Faculty

Faculty, researchers, and trainees of the Public Health Modeling Unit have mobilized to address the COVID-19 Pandemic. This page illustrates the depth of research that has reached publication.

Publications

On this page

2021 Publications

  1. Shelby T, Schenck C, Weeks B, Goodwin J, Hennein R, Zhou X, Spiegelman D, Grau LE, Niccolai L, Bond M, Davis JL. Lessons Learned From COVID-19 Contact Tracing During a Public Health Emergency: A Prospective Implementation Study. Front Public Health. 2021 Aug 20;9:721952. doi: 10.3389/fpubh.2021.721952. PMID: 34490198; PMCID: PMC8417826.
  2. Wells, C. R., Jeffrey P Townsend, Pandey, A., Moghadas, S. M., Krieger, G., Singer, B., ... & Galvani, A. P. (2021). Optimal COVID-19 quarantine and testing strategies. Nature communications, 12(1), 1-9. PMID: 33414470 PMCID: PMC7788536
  3. Wells, C. R., Pandey, A., Fitzpatrick, M. C., Crystal, W. S., Singer, B. H., Moghadas, S. M., ... & Jeffrey P Townsend (2022). Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study.The Lancet Regional Health-Europe, 100304. PMID: 35036981 PMCID: PMC8743228
  4. Jeffrey P Townsend, Hassler, H. B., Wang, Z., Miura, S., Singh, J., Kumar, S., ... & Dornburg, A. (2021). The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. The Lancet Microbe, 2(12), e666-e675. PMID: 34632431 PMCID: PMC8486316
  5. Chang JT, Crawford FW, Kaplan EH. Repeat SARS-CoV-2 testing models for residential college populations. Health Care Manag Sci. 2020 Nov 17:1-14. And Correction to: Repeat SARS-CoV-2 testing models for residential college populations. Health Care Manag Sci. 2021 Jun;24(2):319. doi: 10.1007/s10729-021-09568-y. Erratum for: Health Care Manag Sci. 2021 Jun;24(2):305-318. PMID: 34032980; PMCID: PMC8144865.
  6. Eger W, Herman D, House M, Robinson L, Williams C, Gonsalves G. Confronting A Legacy of Scarcity: A Plan for America’s Re-Investment in Public Health. Global Health Justice Partnership Report, Yale Law School/Yale School of Public Health. 2021
  7. Benfer EA, Vlahov D, Long MY, Walker-Wells E, Pottenger JL Jr, Gonsalves G, Keene DE Eviction, Health Inequity, and the Spread of COVID-19: Housing Policy as a Primary Pandemic Mitigation Strategy..J Urban Health. 2021 Feb;98(1):1-12. doi: 10.1007/s11524-020-00502-1. Epub 2021 Jan 7.PMID: 33415697 And Correction to: Eviction, Health Inequity, and the Spread of COVID-19: Housing Policy as a Primary Pandemic Mitigation Strategy. J Urban Health. 2021 Feb;98(1):159. doi: 10.1007/s11524-021-00519-0. Erratum for: J Urban Health. 2021 Feb;98(1):1-12. PMID: 33492558; PMCID: PMC7831690.
  8. Kumar N, Janmohamed K, Nyhan K, Forastiere L, Zhang WH, Kågesten A, Uhlich M, Van de Velde SM, Francis JM, Erausquin JT, Larsson EC, Callander D, Scott J, Minichiello V, Tucker JD.Sexual health and COVID-19: protocol for a scoping review. Syst Rev. 2021 Jan 23;10(1):37. doi: 10.1186/s13643-021-01591-y.
  9. Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy . Health Aff (Millwood). 2021.
  10. Paltiel AD, Zheng A, Sax PE. Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission. Ann Intern Med. 2021 Jun;174(6):803-810. doi: 10.7326/M21-0510. Epub 2021 Mar 9. PMID: 33683930.
  11. Paltiel AD, Zheng A, Schwartz JL. Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment. Ann Intern Med. 2021.
  12. Sharma R, Kuohn LR, Weinberger DM, Warren JL, Sansing LH, Jasne A, Falcone G, Dhand A, Sheth KN. Excess Cerebrovascular Mortality in the United States During the COVID-19 Pandemic. Stroke 2021 Jan;52(2):563-572. doi: 10.1161/STROKEAHA.120.031975. Epub 2021 Jan 12.PMID: 33430638
  13. Yaesoubi R, Havumaki J, Chitwood MH, Menzies NA, Gonsalves G, Salomon JA, Paltiel AD, Cohen T. Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic. Med Decis Making. 2021
  14. Gonsalves GS, Copple JT, Paltiel AD, Fenichel EP, Bayham J, Abraham M, Kline D, Malloy S, Rayo MF, Zhang N, Faulkner D, Morey DA, Wu F, Thornhill T, Iloglu S, Warren JL. Maximizing the Efficiency of Active Case Finding for SARS-CoV-2 Using Bandit Algorithms. Med Decis Making. 2021 Jun 14:272989X211021603. doi: 10.1177/0272989X211021603. Epub ahead of print. PMID: 34120510.
  15. Ng TC, Cheng HY, Chang HH, Liu CC, Yang CC, Jian SW, Liu DP, Cohen T, Lin HH. Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan. JAMA Intern Med. 2021 Jul 1;181(7):913-921. doi: 10.1001/jamainternmed.2021.1644. PMID: 33821922; PMCID: PMC8025126.
  16. Cheng HY, Cohen T, Lin HH. Test, trace, and isolate in the UK. BMJ. 2021 Mar 31;372:n822. doi: 10.1136/bmj.n822. PMID: 33789886.
  17. Fenichel EP, Koch RT, Gilbert A, Gonsalves G, Wyllie AL. Understanding the Barriers to Pooled SARS-CoV-2 Testing in the United States. Microbiol Spectr. 2021 Aug 11:e0031221. doi: 10.1128/Spectrum.00312-21. Epub ahead of print. PMID: 34378949.
  18. Gonsalves G, Yamey G. The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine". BMJ. 2021 May 17;373:n1249. doi: 10.1136/bmj.n1249. PMID: 34001498.
  19. Ehrlich HY, Harizaj A, Campbell L, Colt M, Yuan K, Rabatsky-Ehr T, Weinberger DM, Leung V, Niccolai LM, Parikh S. SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA. Emerg Infect Dis. 2021 May;27(5):1288-1295. doi: 10.3201/eid2705.204936. PMID: 33900171; PMCID: PMC8084507.
  20. Paltiel, AD and Schwartz JL. Assessing COVID prevention strategies to permit the safe opening of college campuses in fall 2021 Annals of Internal Medicine (in press).
  21. Kissler SM, Fauver JR, Mack C, Olesen SW, Tai C, Shiue KY, Kalinich CC, Jednak S, Ott IM, Vogels CBF, Wohlgemuth J, Weisberger J, DiFiori J, Anderson DJ, Mancell J, Ho DD, Grubaugh ND, Grad YH. Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies. PLoS Biol. 2021 Jul 12;19(7):e3001333. doi: 10.1371/journal.pbio.3001333. PMID: 34252080; PMCID: PMC8297933.
  22. Lucas C, Klein J, Sundaram ME, Liu F, Wong P, Silva J, Mao T, Oh JE, Mohanty S, Huang J, Tokuyama M, Lu P, Venkataraman A, Park A, Israelow B, Vogels CBF, Muenker MC, Chang CH, Casanovas-Massana A, Moore AJ, Zell J, Fournier JB; Yale IMPACT Research Team, Wyllie AL, Campbell M, Lee AI, Chun HJ, Grubaugh ND, Schulz WL, Farhadian S, Dela Cruz C, Ring AM, Shaw AC, Wisnewski AV, Yildirim I, Ko AI, Omer SB, Iwasaki A. Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med. 2021 Jul;27(7):1309. doi: 10.1038/s41591-021-01416-4. Erratum for: Nat Med. 2021 Jul;27(7):1178-1186. PMID: 34145437; PMCID: PMC8212078.
  23. Klein J, Brito A, Trubin P, Lu P, Wong P, Alpert T, Pena-Hernandez M, Haynes W, Kamath K, Liu F, Vogels C, Fauver J, Lucas C, Oh JE, Mao T, Silva J, Wyllie A, Muenker MC, Casanovas-Massana A, Moore A, Petrone M, Kalinich C, Team YIR, Cruz CD, Farhadian S, Ring A, Shon J, Ko A, Grubaugh N, Goldman-Israelow B, Iwasaki A, Azar M. Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient. Res Sq [Preprint]. 2021 May 5:rs.3.rs-405958. doi: 10.21203/rs.3.rs-405958/v1. PMID: 34013255; PMCID: PMC8132249.
  24. Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, Liu F, Zhou T, Israelow B, Wong P, Coppi A, Lucas C, Silva J, Oh JE, Song E, Perotti ES, Zheng NS, Fischer S, Campbell M, Fournier JB, Wyllie AL, Vogels CBF, Ott IM, Kalinich CC, Petrone ME, Watkins AE; Yale IMPACT Team, Dela Cruz C, Farhadian SF, Schulz WL, Ma S, Grubaugh ND, Ko AI, Iwasaki A, Ring AM. Diverse functional autoantibodies in patients with COVID-19. Nature 2021 Jul;595(7866):283-288. doi: 10.1038/s41586-021-03631-y. Epub 2021 May 19. PMID: 34010947.
  25. Lu-Culligan A, Chavan AR, Vijayakumar P, Irshaid L, Courchaine EM, Milano KM, Tang Z, Pope SD, Song E, Vogels CBF, Lu-Culligan WJ, Campbell KH, Casanovas-Massana A, Bermejo S, Toothaker JM, Lee HJ, Liu F, Schulz W, Fournier J, Muenker MC, Moore AJ; Yale IMPACT Team, Konnikova L, Neugebauer KM, Ring A, Grubaugh ND, Ko AI, Morotti R, Guller S, Kliman HJ, Iwasaki A, Farhadian SF. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med (N Y). 2021 May 14;2(5):591-610.e10. doi: 10.1016/j.medj.2021.04.016. Epub 2021 Apr 30. PMID: 33969332; PMCID: PMC8084634.
  26. Song E, Bartley CM, Chow RD, Ngo TT, Jiang R, Zamecnik CR, Dandekar R, Loudermilk RP, Dai Y, Liu F, Sunshine S, Liu J, Wu W, Hawes IA, Alvarenga BD, Huynh T, McAlpine L, Rahman NT, Geng B, Chiarella J, Goldman-Israelow B, Vogels CBF, Grubaugh ND, Casanovas-Massana A, Phinney BS, Salemi M, Alexander JR, Gallego JA, Lencz T, Walsh H, Wapniarski AE, Mohanty S, Lucas C, Klein J, Mao T, Oh J, Ring A, Spudich S, Ko AI, Kleinstein SH, Pak J, DeRisi JL, Iwasaki A, Pleasure SJ, Wilson MR, Farhadian SF. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med. 2021 May 18;2(5):100288. doi: 10.1016/j.xcrm.2021.100288. Epub 2021 May 3. PMID: 33969321; PMCID: PMC8091032.
  27. Novelli G, Biancolella M, Mehrian-Shai R, Colona VL, Brito AF, Grubaugh ND, Vasiliou V, Luzzatto L, Reichardt JKV. COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy. Hum Genomics. 2021 May 10;15(1):27. doi: 10.1186/s40246-021-00326-3. PMID: 33966626; PMCID: PMC8107019
  28. Vogels CBF, Breban MI, Ott IM, Alpert T, Petrone ME, Watkins AE, Kalinich CC, Earnest R, Rothman JE, Goes de Jesus J, Morales Claro I, Magalhães Ferreira G, Crispim MAE; Brazil-UK CADDE Genomic Network, Singh L, Tegally H, Anyaneji UJ; Network for Genomic Surveillance in South Africa, Hodcroft EB, Mason CE, Khullar G, Metti J, Dudley JT, MacKay MJ, Nash M, Wang J, Liu C, Hui P, Murphy S, Neal C, Laszlo E, Landry ML, Muyombwe A, Downing R, Razeq J, de Oliveira T, Faria NR, Sabino EC, Neher RA, Fauver JR, Grubaugh ND. Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2. PLoS Biol. 2021 May 7;19(5):e3001236. doi: 10.1371/journal.pbio.3001236. PMID: 33961632; PMCID: PMC8133773.
  29. Lucas C, Klein J, Sundaram ME, Liu F, Wong P, Silva J, Mao T, Oh JE, Mohanty S, Huang J, Tokuyama M, Lu P, Venkataraman A, Park A, Israelow B, Vogels CBF, Muenker MC, Chang CH, Casanovas-Massana A, Moore AJ, Zell J, Fournier JB; Yale IMPACT Research Team, Wyllie AL, Campbell M, Lee AI, Chun HJ, Grubaugh ND, Schulz WL, Farhadian S, Dela Cruz C, Ring AM, Shaw AC, Wisnewski AV, Yildirim I, Ko AI, Omer SB, Iwasaki A. Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med. 2021 Jul;27(7):1178-1186. doi: 10.1038/s41591-021-01355-0. Epub 2021 May 5. Erratum in: Nat Med. 2021 Jun 18;: PMID: 33953384.
  30. Alpert T, Brito AF, Lasek-Nesselquist E, Rothman J, Valesano AL, MacKay MJ, Petrone ME, Breban MI, Watkins AE, Vogels CBF, Kalinich CC, Dellicour S, Russell A, Kelly JP, Shudt M, Plitnick J, Schneider E, Fitzsimmons WJ, Khullar G, Metti J, Dudley JT, Nash M, Beaubier N, Wang J, Liu C, Hui P, Muyombwe A, Downing R, Razeq J, Bart SM, Grills A, Morrison SM, Murphy S, Neal C, Laszlo E, Rennert H, Cushing M, Westblade L, Velu P, Craney A, Cong L, Peaper DR, Landry ML, Cook PW, Fauver JR, Mason CE, Lauring AS, St George K, MacCannell DR, Grubaugh ND. Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States. Cell. 2021 May 13;184(10):2595-2604.e13. doi: 10.1016/j.cell.2021.03.061. Epub 2021 Apr 3. PMID: 33891875; PMCID: PMC8018830.
  31. Ott IM, Strine MS, Watkins AE, Boot M, Kalinich CC, Harden CA, Vogels CBF, Casanovas-Massana A, Moore AJ, Muenker MC, Nakahata M, Tokuyama M, Nelson A, Fournier J, Bermejo S, Campbell M, Datta R, Dela Cruz CS, Farhadian SF, Ko AI, Iwasaki A, Grubaugh ND, Wilen CB, Wyllie AL; Yale IMPACT Research team3. Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva. Emerg Infect Dis. 2021 Apr;27(4):1146-1150. doi: 10.3201/eid2704.204199. PMID: 33754989; PMCID: PMC8007305.
  32. Vogels CBF, Watkins AE, Harden CA, Brackney DE, Shafer J, Wang J, Caraballo C, Kalinich CC, Ott IM, Fauver JR, Kudo E, Lu P, Venkataraman A, Tokuyama M, Moore AJ, Muenker MC, Casanovas-Massana A, Fournier J, Bermejo S, Campbell M, Datta R, Nelson A; Yale IMPACT Research Team, Dela Cruz CS, Ko AI, Iwasaki A, Krumholz HM, Matheus JD, Hui P, Liu C, Farhadian SF, Sikka R, Wyllie AL, Grubaugh ND. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2021 Mar 12;2(3):263-280.e6. doi: 10.1016/j.medj.2020.12.010. Epub 2020 Dec 26. PMID: 33521748; PMCID: PMC7836249.
  33. Weiss JJ, Attuquayefio TN, White EB, Li F, Herz RS, White TL, Campbell M, Geng B, Datta R, Wyllie AL, Grubaugh ND, Casanovas-Massana A, Muenker MC, Moore AJ, Handoko R, Iwasaki A, Martinello RA, Ko AI, Small DM, Farhadian SF; Yale IMPACT Research Team. Tracking smell loss to identify healthcare workers with SARS-CoV-2 infection. PLoS One. 2021 Mar 3;16(3):e0248025. doi: 10.1371/journal.pone.0248025. PMID: 33657167; PMCID: PMC7928484.
  34. Peters J, Alhasan S, Vogels CBF, Grubaugh ND, Farhadian S, Longbrake EE. MOG-associated encephalitis following SARS-COV-2 infection. Mult Scler Relat Disord. 2021 May;50:102857. doi: 10.1016/j.msard.2021.102857. Epub 2021 Feb 23. PMID: 33647592; PMCID: PMC7900751.
  35. Grubaugh ND, Hodcroft EB, Fauver JR, Phelan AL, Cevik M. Public health actions to control new SARS-CoV-2 variants. Cell. 2021 Mar 4;184(5):1127-1132. doi: 10.1016/j.cell.2021.01.044. Epub 2021 Jan 29. PMID: 33581746; PMCID: PMC7846239.
  36. Wyllie AL, Vogels CBF, Grubaugh ND. Saliva for Detection of SARS-CoV-2. Reply. N Engl J Med. 2021 Mar 4;384(9):e31. doi: 10.1056/NEJMc2032165. Epub 2021 Feb 3. PMID: 33534974.
  37. Kudo E, Israelow B, Vogels CBF, Lu P, Wyllie AL, Tokuyama M, Venkataraman A, Brackney DE, Ott IM, Petrone ME, Earnest R, Lapidus S, Muenker MC, Moore AJ, Casanovas-Massana A; Yale IMPACT Research Team, Omer SB, Dela Cruz CS, Farhadian SF, Ko AI, Grubaugh ND, Iwasaki A. Detection of SARS-CoV-2 RNA by multiplex RT-qPCR. PLoS Biol. 2020 Oct 7;18(10):e3000867. doi: 10.1371/journal.pbio.3000867. PMID: 33027248; PMCID: PMC7571696.
  38. Borghi E, Massa V, Zuccotti G, Wyllie AL. Testing Saliva to Reveal the Submerged Cases of the COVID-19 Iceberg. Front Microbiol. 2021 Jul 12;12:721635. doi: 10.3389/fmicb.2021.721635. PMID: 34322114; PMCID: PMC8312273.
  39. Mendoza RP, Bi C, Cheng HT, Gabutan E, Pagaspas GJ, Khan N, Hoxie H, Hanna S, Holmes K, Gao N, Lewis R, Wang H, Neumann D, Chan A, Takizawa M, Lowe J, Chen X, Kelly B, Asif A, Barnes K, Khan N, May B, Chowdhury T, Pollonini G, Gouda N, Guy C, Gordon C, Ayoluwa N, Colon E, Miller-Medzon N, Jones S, Hossain R, Dodson A, Weng M, McGaskey M, Vasileva A, Lincoln AE, Sikka R, Wyllie AL, Berke EM, Libien J, Pincus M, Premsrirut PK. Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections in K-12 schools and universities. EClinicalMedicine. 2021 Aug;38:101028. doi: 10.1016/j.eclinm.2021.101028. Epub 2021 Jul 17. PMID: 34308321; PMCID: PMC8286123.
  40. Tan SH, Allicock O, Armstrong-Hough M, Wyllie AL. Saliva as a gold-standard sample for SARS-CoV-2 detection. Lancet Respir Med. 2021 Jun;9(6):562-564. doi: 10.1016/S2213-2600(21)00178-8. Epub 2021 Apr 19. PMID: 33887248; PMCID: PMC8055204.
  41. Lopez WD, Kline N, LeBrón AMW, Novak NL, De Trinidad Young ME, Gonsalves G, Mishori R, Safi BA, Kysel IM Preventing the Spread of COVID-19 in Immigration Detention Centers Requires the Release of Detainees. Am J Public Health. 2021 Jan;111(1):110-115. doi: 10.2105/AJPH.2020.305968. Epub 2020 Nov 19.PMID: 33211577 medRxiv. 2020 Jun 19:2020.06.16.20126425.
  42. Chitwood MH, Russi M, Gunasekera K, Havumaki J, Klaassen F, Pitzer VE, Salomon JA, Swartwood NA, Warren JL, Weinberger DM, Cohen T, Menzies NA. Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: results of a Bayesian evidence synthesis model. medRxiv [Preprint]. 2021 Jul 22:2020.06.17.20133983. doi: 10.1101/2020.06.17.20133983. PMID: 33851183; PMCID: PMC8043480.
  43. Morozova O, Li ZR, Crawford FW. One year of modeling and forecasting COVID-19 transmission to support policymakers in Connecticut. medRxiv [Preprint]. 2021 Apr 23:2020.06.12.20126391. doi: 10.1101/2020.06.12.20126391. PMID: 32587978; PMCID: PMC7310630.
  44. Crawford FW, Jones SA, Cartter M, Dean SG, Warren JL, Li ZR, Barbieri J, Campbell J, Kenney P, Valleau T, Morozova O. Impact of close interpersonal contact on COVID-19 incidence: evidence from one year of mobile device data. medRxiv [Preprint]. 2021 Mar 12:2021.03.10.21253282. doi: 10.1101/2021.03.10.21253282. PMID: 33758869; PMCID: PMC7987027.
  45. Perniciaro SR, Weinberger DM. 50 policies, 1 pandemic, 500,000 deaths: Associations between state-level COVID-19 testing recommendations, tests per capita, undercounted deaths, vaccination policies, and doses per capita in the United States. medRxiv [Preprint]. 2021 Feb 26:2020.09.04.20188326. doi: 10.1101/2020.09.04.20188326. PMID: 33200142; PMCID: PMC7668755.
  46. Petrone ME, Rothman JE, Breban MI, Ott IM, Russell A, Lasek-Nesselquist E, Kelly K, Omerza G, Renzette N, Watkins AE, Kalinich CC, Alpert T, Brito AF, Earnest R, Tikhonova IR, Castaldi C, Kelly JP, Shudt M, Plitnick J, Schneider E, Murphy S, Neal C, Laszlo E, Altajar A, Pearson C, Muyombwe A, Downing R, Razeq J, Niccolai L, Wilson MS, Anderson ML, Wang J, Liu C, Hui P, Mane S, Taylor BP, Hanage WP, Landry ML, Peaper DR, Bilguvar K, Fauver JR, Vogels CBF, Gardner LM, Pitzer VE, George KS, Adams MD, Grubaugh ND. Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages. medRxiv [Preprint]. 2021 Jul 2:2021.07.01.21259859. doi: 10.1101/2021.07.01.21259859. PMID: 34230938; PMCID: PMC8259915.
  47. Schultes O, Clarke V, Paltiel AD, Cartter M, Sosa L, Crawford FW. COVID-19 in Connecticut institutions of higher education during the 2020-2021 academic year medRxiv 2021.08.11.21261732; doi: https://doi.org/10.1101/2021.08.11.21261732.
  48. Alpert T, Vogels CBF, Breban MI, Petrone ME; Yale IMPACT Research Team, Wyllie AL, Grubaugh ND, Fauver JR. Sequencing SARS-CoV-2 Genomes from Saliva. medRxiv [Preprint]. 2021 Jun 29:2021.06.21.21259289. doi: 10.1101/2021.06.21.21259289. PMID: 34230934; PMCID: PMC8259911.
  49. Mao T, Israelow B, Lucas C, Vogels CBF, Fedorova O, Breban MI, Menasche BL, Dong H, Linehan M; Yale SARS-CoV-2 Genome Surveillance Initiative, Wilen CB, Landry ML, Grubaugh ND, Pyle AM, Iwasaki A. A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in mice. bioRxiv [Preprint]. 2021 Jun 17:2021.06.16.448754. doi: 10.1101/2021.06.16.448754. PMID: 34159330; PMCID: PMC8219094.
  50. Allicock OM, Petrone ME, Yolda-Carr D, Breban M, Walsh H, Watkins AE, Rothman JE, Farhadian SF, Grubaugh ND, Wyllie AL. Evaluation of saliva self-collection devices for SARS-CoV-2 diagnostics. medRxiv [Preprint]. 2021 Jul 3:2021.02.01.21250946. doi: 10.1101/2021.02.01.21250946. PMID: 33564787; PMCID: PMC7872382.
  51. Zeller M, Gangavarapu K, Anderson C, Smither AR, Vanchiere JA, Rose R, Dudas G, Snyder DJ, Watts A, Matteson NL, Robles-Sikisaka R, Marshall M, Feehan AK, Sabino-Santos G, Bell-Kareem A, Hughes LD, Alkuzweny M, Snarski P, Garcia-Diaz J, Scott RS, Melnik LI, Klitting R, McGraw M, Belda-Ferre P, DeHoff P, Sathe S, Marotz C, Grubaugh N, Nolan DJ, Drouin AC, Genemaras KJ, Chao K, Topol S, Spencer E, Nicholson L, Aigner S, Yeo GW, Farnaes L, Hobbs CA, Laurent LC, Knight R, Hodcroft EB, Khan K, Fusco DN, Cooper VS, Lemey P, Gardner L, Lamers SL, Kamil JP, Garry RF, Suchard MA, Andersen KG. Emergence of an early SARS-CoV-2 epidemic in the United States. medRxiv [Preprint]. 2021 Feb 8:2021.02.05.21251235. doi: 10.1101/2021.02.05.21251235. PMID: 33564781; PMCID: PMC7872376.
  52. Lu-Culligan A, Chavan AR, Vijayakumar P, Irshaid L, Courchaine EM, Milano KM, Tang Z, Pope SD, Song E, Vogels CBF, Lu-Culligan WJ, Campbell KH, Casanovas-Massana A, Bermejo S, Toothaker JM, Lee HJ, Liu F, Schulz W, Fournier J, Muenker MC, Moore AJ; Yale IMPACT Team, Konnikova L, Neugebauer KM, Ring A, Grubaugh ND, Ko AI, Morotti R, Guller S, Kliman HJ, Iwasaki A, Farhadian SF. SARS-CoV-2 infection in pregnancy is associated with robust inflammatory response at the maternal-fetal interface. medRxiv [Preprint]. 2021 Jan 26:2021.01.25.21250452. doi: 10.1101/2021.01.25.21250452. Update in: Med (N Y). 2021 May 14;2(5):591-610.e10. PMID: 33532791; PMCID: PMC7852242.
  53. Silva J, Lucas C, Sundaram M, Israelow B, Wong P, Klein J, Tokuyama M, Lu P, Venkataraman A, Liu F, Mao T, Oh JE, Park A, Casanovas-Massana A, Vogels CBF, Muenker CM, Zell J, Fournier JB, Campbell M, Chiorazzi M, Ruiz Fuentes E, Petrone M, Kalinich CC, Ott IM, Watkins A, Moore AJ, Nakahata MI, Grubaugh ND, Farhadian S, Dela Cruz C, Ko A, Schulz WL, Ring AM, Ma S, Omer S, Wyllie AL, Iwasaki A. Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality. medRxiv [Preprint]. 2021 Jan 10:2021.01.04.21249236. doi: 10.1101/2021.01.04.21249236. PMID: 33442706; PMCID: PMC7805468.

2020 Publications

  1. Fauver JR, Petrone ME, Hodcroft EB, Shioda K, Ehrlich HY, Watts AG, Vogels CBF, Brito AF, Alpert T, Muyombwe A, Razeq J, Downing R, Cheemarla NR, Wyllie AL, Kalinich CC, Ott IM, Quick J, Loman NJ, Neugebauer KM, Greninger AL, Jerome KR, Roychoudhury P, Xie H, Shrestha L, Huang ML, Pitzer VE, Iwasaki A, Omer SB, Khan K, Bogoch II, Martinello RA, Foxman EF, Landry ML, Neher RA, Ko AI, Grubaugh ND. Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell. 2020 May 28;181(5):990-996.e5. doi: 10.1016/j.cell.2020.04.021. Epub 2020 May 7.PMID: 3238654
  2. Gonsalves G, Yamey G Political interference in public health science during covid-19. BMJ. 2020 Oct 6;371:m3878. doi: 10.1136/bmj.m3878.PMID: 33023874
  3. Krieger N, Gonsalves G, Bassett MT, Hanage w, Krumholz HM. The fierce urgency of now: closing glaring gaps in US surveillance data on COVID-19. Health Affairs Blog. 14 April 2020.
  4. Oladeru OT, Beckman A, Gonsalves G. What COVID-19 Means for America’s Incarcerated Population — And How to Ensure It’s Not Left Behind. Health Affairs Blog. 10 March 2020.
  5. Gonsalves G, Kapczynski A. The New Politics of Care. Boston Review: A Political and Literary Forum; 2020.
  6. Gonsalves G, Kapczynski A. Markets V. Lives. Boston Review: A Political and Literary Forum; 2020.
  7. Kapczynski A, Gonsalves G. Alone Against the Virus. Boston Review: A Political and Literary Forum; 2020.
  8. Janmohamed K, Soale AN, Forastiere L, Tang W, Sha Y, Demant J, Airoldi E, Kumar N.J Intersection of the Web-Based Vaping Narrative With COVID-19: Topic Modeling Study. Med Internet Res. 2020 Oct 30;22(10):e21743. doi: 10.2196/21743.PMID: 33001829
  9. Paltiel AD, Zheng A, Walensky RP. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States. JAMA Netw Open. 2020.
  10. Peccia J, Zulli A, Brackney DE, Grubaugh ND, Kaplan EH, Casanovas-Massana A, Ko AI, Malik AA, Wang D, Wang M, Warren JL, Weinberger DM, Arnold W, Omer SB. Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics. Nat Biotechnol. 2020 Oct;38(10):1164-1167. doi: 10.1038/s41587-020-0684-z. Epub 2020 Sep 18.PMID: 32948856
  11. Pitzer VE, Cohen T. Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2. .Lancet Infect Dis. 2020 Oct;20(10):1103-1104. doi: 10.1016/S1473-3099(20)30514-4. Epub 2020 Jun 17.PMID: 32562602.
  12. Shioda K, Weinberger DM, Mori M Navigating Through Health Care Data Disrupted by the COVID-19 Pandemic. .JAMA Intern Med. 2020 Dec 1;180(12):1569-1570. doi: 10.1001/jamainternmed.2020.5542.PMID: 33044501 No abstract available.
  13. Vermund SH, Pitzer VE.Asymptomatic transmission and the infection fatality risk for COVID-19: Implications for school reopening. Clin Infect Dis. 2020 Jun 25:ciaa855. doi: 10.1093/cid/ciaa855. Online ahead of print. PMID: 32584967
  14. Weinberger DM, Chen J, Cohen T, Crawford FW, Mostashari F, Olson D, Pitzer VE, Reich NG, Russi M, Simonsen L, Watkins A, Viboud C. Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020. JAMA Intern Med. 2020 Oct 1;180(10):1336-1344.
  15. Weinstein MC, Freedberg KA, Hyle EP, Paltiel AD.Waiting for Certainty on Covid-19 Antibody Tests - At What Cost? N Engl J Med. 2020 Aug 6;383(6):e37.
  16. Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L, Taylor DDH Excess Deaths From COVID-19 and Other Causes, March-July 2020..JAMA. 2020 Oct 20;324(15):1562-1564. doi: 10.1001/jama.2020.19545.PMID: 33044483
  17. Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L. Excess Deaths From COVID-19 and Other Causes, March-April 2020. JAMA. 2020 Aug 4;324(5):510-513. doi: 10.1001/jama.2020.11787.
  18. Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, Warren JL, Geng B, Muenker MC, Moore AJ, Vogels CBF, Petrone ME, Ott IM, Lu P, Venkataraman A, Lu-Culligan A, Klein J, Earnest R, Simonov M, Datta R, Handoko R, Naushad N, Sewanan LR, Valdez J, White EB, Lapidus S, Kalinich CC, Jiang X, Kim DJ, Kudo E, Linehan M, Mao T, Moriyama M, Oh JE, Park A, Silva J, Song E, Takahashi T, Taura M, Weizman OE, Wong P, Yang Y, Bermejo S, Odio CD, Omer SB, Dela Cruz CS, Farhadian S, Martinello RA, Iwasaki A, Grubaugh ND, Ko AI. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med. 2020 Sep 24;383(13):1283-1286. doi: 10.1056/NEJMc2016359. Epub 2020 Aug 28. PMID: 32857487; PMCID: PMC7484747.
  19. Yamey G, Gonsalves G.Donald Trump: a political determinant of covid-19. BMJ. 2020 Apr 24;369:m1643. doi: 10.1136/bmj.m1643. PMID: 32332028.
  20. Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, Warren JL, Geng B, Muenker MC, Moore AJ, Vogels CBF, Petrone ME, Ott IM, Lu P, Venkataraman A, Lu-Culligan A, Klein J, Earnest R, Simonov M, Datta R, Handoko R, Naushad N, Sewanan LR, Valdez J, White EB, Lapidus S, Kalinich CC, Jiang X, Kim DJ, Kudo E, Linehan M, Mao T, Moriyama M, Oh JE, Park A, Silva J, Song E, Takahashi T, Taura M, Weizman OE, Wong P, Yang Y, Bermejo S, Odio CD, Omer SB, Dela Cruz CS, Farhadian S, Martinello RA, Iwasaki A, Grubaugh ND, Ko AI. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med. 2020 Sep 24;383(13):1283-1286. doi: 10.1056/NEJMc2016359. Epub 2020 Aug 28. PMID: 32857487; PMCID: PMC7484747.
  21. Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, Silva J, Mao T, Oh JE, Tokuyama M, Lu P, Venkataraman A, Park A, Liu F, Meir A, Sun J, Wang EY, Casanovas-Massana A, Wyllie AL, Vogels CBF, Earnest R, Lapidus S, Ott IM, Moore AJ; Yale IMPACT Research Team, Shaw A, Fournier JB, Odio CD, Farhadian S, Dela Cruz C, Grubaugh ND, Schulz WL, Ring AM, Ko AI, Omer SB, Iwasaki A. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020 Dec;588(7837):315-320. doi: 10.1038/s41586-020-2700-3. Epub 2020 Aug 26. PMID: 32846427; PMCID: PMC7725931.
  22. Kalinich CC, Jensen CG, Neugebauer P, Petrone ME, Peña-Hernández M, Ott IM, Wyllie AL, Alpert T, Vogels CBF, Fauver JR, Grubaugh ND, Brito AF. Real-time public health communication of local SARS-CoV-2 genomic epidemiology. PLoS Biol. 2020 Aug 21;18(8):e3000869. doi: 10.1371/journal.pbio.3000869. PMID: 32822393; PMCID: PMC7467297.
  23. Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, Ellingson MK, Mao T, Oh JE, Israelow B, Takahashi T, Tokuyama M, Lu P, Venkataraman A, Park A, Mohanty S, Wang H, Wyllie AL, Vogels CBF, Earnest R, Lapidus S, Ott IM, Moore AJ, Muenker MC, Fournier JB, Campbell M, Odio CD, Casanovas-Massana A; Yale IMPACT Team, Herbst R, Shaw AC, Medzhitov R, Schulz WL, Grubaugh ND, Dela Cruz C, Farhadian S, Ko AI, Omer SB, Iwasaki A. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020 Aug;584(7821):463-469. doi: 10.1038/s41586-020-2588-y. Epub 2020 Jul 27. PMID: 32717743; PMCID: PMC7477538.
  24. Farhadian S, Glick LR, Vogels CBF, Thomas J, Chiarella J, Casanovas-Massana A, Zhou J, Odio C, Vijayakumar P, Geng B, Fournier J, Bermejo S, Fauver JR, Alpert T, Wyllie AL, Turcotte C, Steinle M, Paczkowski P, Cruz CD, Wilen C, Ko AI, MacKay S, Grubaugh ND, Spudich S, Aoun Barakat L. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. Res Sq [Preprint]. 2020 May 12:rs.3.rs-28583. doi: 10.21203/rs.3.rs-28583/v1. Update in: BMC Neurol. 2020 Jun 18;20(1):248. PMID: 32702723; PMCID: PMC7336693.
  25. Grubaugh ND, Hanage WP, Rasmussen AL. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear. Cell. 2020 Aug 20;182(4):794-795. doi: 10.1016/j.cell.2020.06.040. Epub 2020 Jul 3. PMID: 32697970; PMCID: PMC7332445.
  26. Vogels CBF, Brito AF, Wyllie AL, Fauver JR, Ott IM, Kalinich CC, Petrone ME, Casanovas-Massana A, Catherine Muenker M, Moore AJ, Klein J, Lu P, Lu-Culligan A, Jiang X, Kim DJ, Kudo E, Mao T, Moriyama M, Oh JE, Park A, Silva J, Song E, Takahashi T, Taura M, Tokuyama M, Venkataraman A, Weizman OE, Wong P, Yang Y, Cheemarla NR, White EB, Lapidus S, Earnest R, Geng B, Vijayakumar P, Odio C, Fournier J, Bermejo S, Farhadian S, Dela Cruz CS, Iwasaki A, Ko AI, Landry ML, Foxman EF, Grubaugh ND. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol. 2020 Oct;5(10):1299-1305. doi: 10.1038/s41564-020-0761-6. Epub 2020 Jul 10. PMID: 32651556.
  27. Takahashi T, Wong P, Ellingson MK, Lucas C, Klein J, Israelow B, Silva J, Oh JE, Mao T, Tokuyama M, Lu P, Venkataraman A, Park A, Liu F, Meir A, Sun J, Wang EY, Wyllie AL, Vogels CBF, Earnest R, Lapidus S, Ott IM, Moore AJ, Casanovas-Massana A, Cruz CD, Fournier JB, Odio CD, Farhadian S, Grubaugh ND, Schulz WL, Ko AI, Ring AM, Omer SB, Iwasaki A; Yale IMPACT research team. Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes. medRxiv [Preprint]. 2020 Jun 26:2020.06.06.20123414. doi: 10.1101/2020.06.06.20123414. Update in: Nature. 2020 Dec;588(7837):315-320. PMID: 32577695; PMCID: PMC7302304.
  28. Hosier H, Farhadian SF, Morotti RA, Deshmukh U, Lu-Culligan A, Campbell KH, Yasumoto Y, Vogels CB, Casanovas-Massana A, Vijayakumar P, Geng B, Odio CD, Fournier J, Brito AF, Fauver JR, Liu F, Alpert T, Tal R, Szigeti-Buck K, Perincheri S, Larsen C, Gariepy AM, Aguilar G, Fardelmann KL, Harigopal M, Taylor HS, Pettker CM, Wyllie AL, Cruz CD, Ring AM, Grubaugh ND, Ko AI, Horvath TL, Iwasaki A, Reddy UM, Lipkind HS. SARS-CoV-2 infection of the placenta. J Clin Invest. 2020 Sep 1;130(9):4947-4953. doi: 10.1172/JCI139569. PMID: 32573498; PMCID: PMC7456249.
  29. Farhadian S, Glick LR, Vogels CBF, Thomas J, Chiarella J, Casanovas-Massana A, Zhou J, Odio C, Vijayakumar P, Geng B, Fournier J, Bermejo S, Fauver JR, Alpert T, Wyllie AL, Turcotte C, Steinle M, Paczkowski P, Dela Cruz C, Wilen C, Ko AI, MacKay S, Grubaugh ND, Spudich S, Barakat LA. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol. 2020 Jun 18;20(1):248. doi: 10.1186/s12883-020-01812-2. PMID: 32552792; PMCID: PMC7301053.
  30. Mavian C, Pond SK, Marini S, Magalis BR, Vandamme AM, Dellicour S, Scarpino SV, Houldcroft C, Villabona-Arenas J, Paisie TK, Trovão NS, Boucher C, Zhang Y, Scheuermann RH, Gascuel O, Lam TT, Suchard MA, Abecasis A, Wilkinson E, de Oliveira T, Bento AI, Schmidt HA, Martin D, Hadfield J, Faria N, Grubaugh ND, Neher RA, Baele G, Lemey P, Stadler T, Albert J, Crandall KA, Leitner T, Stamatakis A, Prosperi M, Salemi M. Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable. Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12522-12523. doi: 10.1073/pnas.2007295117. Epub 2020 May 7. PMID: 32381734; PMCID: PMC7293693.
  31. Iwasaki A, Grubaugh ND. Why does Japan have so few cases of COVID-19? EMBO Mol Med. 2020 May 8;12(5):e12481. doi: 10.15252/emmm.202012481. Epub 2020 Apr 28. PMID: 32275804; PMCID: PMC7207161.
  32. Grubaugh ND, Petrone ME, Holmes EC. We shouldn't worry when a virus mutates during disease outbreaks. Nat Microbiol. 2020 Apr;5(4):529-530. doi: 10.1038/s41564-020-0690-4. PMID: 32071422; PMCID: PMC7095397.
  33. Morozova O, Li ZR, Crawford FW. A model for COVID-19 transmission in Connecticut. medRxiv. 2020 Jun 16:2020.06.12.20126391. doi: 10.1101/2020.06.12.20126391.
  34. Perniciaro SR, Weinberger DMVariations in state-level SARS-COV-2 testing recommendations in the United States, March-July 2020..medRxiv. 2020 Nov 15:2020.09.04.20188326. doi: 10.1101/2020.09.04.20188326.
  35. Pitzer VE, Chitwood M, Havumaki J, Menzies NA, Perniciaro S, Warren JL, Weinberger DM, Cohen T. The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States. medRxiv. 2020 Apr 24:2020.04.20.20073338. doi: 10.1101/2020.04.20.20073338.
  36. Schonberger RB, Listokin YJ, Ayres I, Yaesoubi R, Shelley ZR. Cost Benefit Analysis of Limited Reopening Relative to a Herd Immunity Strategy or Shelter in Place for SARS-CoV-2 in the United States. medRxiv. 2020 Jun 28:2020.06.26.20141044. doi: 10.1101/2020.06.26.20141044. Preprint.PMID: 32607526
  37. Watkins AE, Fenichel EP, Weinberger DM, Vogels CBF, Brackney DE, Casanovas-Massana A, Campbell M, Fournier J, Bermejo S, Datta R, Dela Cruz CS, Farhadian SF, Iwasaki A, Ko AI, Grubaugh ND, Wyllie ALPooling saliva to increase SARS-CoV-2 testing capacity. medRxiv. 2020 Sep 3:2020.09.02.20183830. doi: 10.1101/2020.09.02.20183830. Preprint. PMID: 32909003
  38. Weinberger DM, Cohen T, Crawford FW, Mostashari F, Olson D, Pitzer VE, Reich NG, Russi M, Simonsen L, Watkins A, Viboud C. Estimating the early death toll of COVID-19 in the United States. bioRxiv. 2020 Apr 18:2020.04.15.20066431. doi: 10.1101/2020.04.15.20066431. Preprint. PMID: 32511293
  39. Lucas C, Klein J, Sundaram M, Liu F, Wong P, Silva J, Mao T, Oh JE, Tokuyama M, Lu P, Venkataraman A, Park A, Israelow B, Wyllie AL, Vogels CBF, Muenker MC, Casanovas-Massana A, Schulz WL, Zell J, Campbell M, Fournier JB, Grubaugh ND, Farhadian S, Wisnewski AV, Cruz CD, Omer S, Ko AI, Ring A, Iwasaki A. Kinetics of antibody responses dictate COVID-19 outcome. medRxiv [Preprint]. 2020 Dec 22:2020.12.18.20248331. doi: 10.1101/2020.12.18.20248331. PMID: 33398304; PMCID: PMC7781347.
  40. Song E, Bartley CM, Chow RD, Ngo TT, Jiang R, Zamecnik CR, Dandekar R, Loudermilk RP, Dai Y, Liu F, Hawes IA, Alvarenga BD, Huynh T, McAlpine L, Rahman NT, Geng B, Chiarella J, Goldman-Israelow B, Vogels CBF, Grubaugh ND, Casanovas-Massana A, Phinney BS, Salemi M, Alexander J, Gallego JA, Lencz T, Walsh H, Lucas C, Klein J, Mao T, Oh J, Ring A, Spudich S, Ko AI, Kleinstein SH, DeRisi JL, Iwasaki A, Pleasure SJ, Wilson MR, Farhadian SF. Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement. bioRxiv [Preprint]. 2020 Dec 9:2020.09.11.293464. doi: 10.1101/2020.09.11.293464. Update in: Cell Rep Med. 2021 May 18;2(5):100288. PMID: 32935102; PMCID: PMC7491516.
  41. Ott IM, Strine MS, Watkins AE, Boot M, Kalinich CC, Harden CA, Vogels CBF, Casanovas-Massana A, Moore AJ, Muenker MC, Nakahata M, Tokuyama M, Nelson A, Fournier J, Bermejo S, Campbell M, Datta R, Dela Cruz CS, Farhadian SF, Ko AI, Iwasaki A, Grubaugh ND, Wilen CB, Wyllie AL. Simply saliva: stability of SARS-CoV-2 detection negates the need for expensive collection devices. medRxiv [Preprint]. 2020 Aug 4:2020.08.03.20165233. doi: 10.1101/2020.08.03.20165233. PMID: 32793924; PMCID: PMC7418742.
  42. Moore AJ, Nakahata MI, Kalinich CC, Nyhan K, Bromberg DJ, Shi X, Ko AI, Grubaugh ND, Casanovas-Massana A, Wyllie AL. The Sensitivity of Respiratory Tract Specimens for the Detection of SARS-CoV-2: A Protocol for a Living Systematic Review and Meta-Analysis. medRxiv [Preprint]. 2020 Jul 4:2020.07.02.20144543. doi: 10.1101/2020.07.02.20144543. PMID: 32637978; PMCID: PMC7340204.
  43. Cheemarla NR, Brito AF, Fauver JR, Alpert T, Vogels CBF, Omer SB, Ko A, Grubaugh ND, Landry ML, Foxman EF. Host response-based screening to identify undiagnosed cases of COVID-19 and expand testing capacity. medRxiv [Preprint]. 2020 Jun 5:2020.06.04.20109306. doi: 10.1101/2020.06.04.20109306. PMID: 32577694; PMCID: PMC7302303.
  44. Crawford FW, Li ZR, Morozova O. COVID-19 projections for reopening Connecticut. medRxiv [Preprint]. 2020 Jun 19:2020.06.16.20126425. doi: 10.1101/2020.06.16.20126425. PMID: 32588003; PMCID: PMC7310663.
  45. Weiss JJ, Attuquayefio TN, White EB, Li F, Herz RS, White TL, Campbell M, Geng B, Datta R, Wyllie AL, Grubaugh ND, Casanovas-Massana A, Muenker MC, Handoko R, Iwasaki A; Yale IMPACT Research Team, Martinello RA, Ko AI, Small DM, Farhadian SF. Tracking Smell Loss to Identify Healthcare Workers with SARS-CoV-2 Infection. medRxiv [Preprint]. 2020 Sep 10:2020.09.07.20188813. doi: 10.1101/2020.09.07.20188813. Update in: PLoS One. 2021 Mar 3;16(3):e0248025. PMID: 32935121; PMCID: PMC7491536.